Brief: Design Therapeutics Q4 operating loss USD 19.392 million
14/03/2023 20:23
Mar 14 (Reuters) - Design Therapeutics Q4 operating income USD -19.392 million. * Q4 operating expenses USD 19.392 million * Q4 net income USD -17.34 million * Q4 EPS USD -0.31
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1